The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease
International Journal of Molecular Sciences · 25.01.2023 · 24 (3) · 2399
DOI: 10.3390/ijms24032399 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2023. Verfasst von Racha El Hage und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Universitätsklinikum Ruppin-Brandenburg, Medizinische Hochschule Brandenburg, Fehrbelliner Str. 38, 16816 Neuruppin, …. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Atherosclerosis. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 207 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin Berlin and the German Research Foundation (DFG).
Abstract (Originalsprache)
The gut microbiome plays a major role in human health, and gut microbial imbalance or dysbiosis is associated with disease development. Modulation in the gut microbiome can be used to treat or prevent different diseases. Gut dysbiosis increases with aging, and it has been associated with the impairment of gut barrier function leading to the leakage of harmful metabolites such as trimethylamine (TMA). TMA is a gut metabolite resulting from dietary amines that originate from animal-based foods. TMA enters the portal circulation and is oxidized by the hepatic enzyme into trimethylamine oxide (TMAO). Increased TMAO levels have been reported in elderly people. High TMAO levels are linked to peripheral artery disease (PAD), endothelial senescence, and vascular aging. Emerging evidence showed the beneficial role of probiotics and prebiotics in the management of several atherogenic risk factors through the remodeling of the gut microbiota, thus leading to a reduction in TMAO levels and atherosclerotic lesions. Despite the promising outcomes in different studies, the definite mechanisms of gut dysbiosis and microbiota-derived TMAO involved in atherosclerosis remain not fully understood. More studies are still required to focus on the molecular mechanisms and precise treatments targeting gut microbiota and leading to atheroprotective effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Vascular Surgery, Universitätsklinikum Ruppin-Brandenburg, Medizinische Hochschule Brandenburg, Fehrbelliner Str. 38, 16816 Neuruppin, Germany.
- Vascular Surgery Clinic, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health (BIH), 10117 Berlin, Germany.
- Fakultät für Gesundheitswissenschaften Brandenburg, Gemeinsame Fakultät der Universität Potsdam, der Medizinischen Hochschule Brandenburg Theodor Fontane und der Brandenburgischen Technischen Universität Cottbus-Senften…
ORCID-Profile: Irene Hinterseher
Förderung
- Universitätsmedizin Berlin and the German Research Foundation (DFG)
Zitieren
APA
El Hage, R., Al-Arawe, N., & Hinterseher, I. (2023). The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. International Journal of Molecular Sciences, 24(3), 2399. https://doi.org/10.3390/ijms24032399
Vancouver
El Hage R, Al-Arawe N, Hinterseher I. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease. International Journal of Molecular Sciences. 2023;24(3):2399. doi:10.3390/ijms24032399
BibTeX
@article{ElHage2023,
author = {El Hage, Racha and Al-Arawe, Nada and Hinterseher, Irene},
title = {The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2399},
doi = {10.3390/ijms24032399}
}
EUVIMED